Key result
A 2-hour urokinase regimen exhibited similar efficacy to the standard 12-hour regimen in patients with acute pulmonary embolism, showing comparable rates of improvement in pulmonary artery obstruction at 14 days.
Why the study?
Does a 2-hour urokinase regimen (20,000 U/kg) exhibit similar efficacy and safety compared to a 12-hour regimen (2,200 U/kg/h) in patients with acute pulmonary embolism?
RCT (n=129)
Open-label
Computerized randomization program
Yes
Does a 2-hour urokinase regimen (20,000 U/kg) exhibit similar efficacy and safety compared to a 12-hour regimen (2,200 U/kg/h) in patients with acute pulmonary embolism?
A 2-hour urokinase regimen demonstrates similar efficacy and safety to the standard 12-hour regimen for the treatment of acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Supports accelerated 2-hour urokinase for acute PE; extends evidence for shorter thrombolytic regimens with comparable safety.
BACKGROUNDS: Urokinase (UK) 2 200 U/kg.h for 12 hours infusion(UK-12 h)is an ACCP recommended regimen in treating acute pulmonary embolism (PE). It is unclear whether this dose and time can be reduced further. We compared the efficacy and safety of 20, 000 U/kg for 2 hours (UK-2 h) with the UK-12 h regime in selected PE patients. METHODS: A randomized trial involving 129 patients was conducted. Patients with acute PE were randomly assigned to receive either UK-12 h (n = 70), or UK-2 h (n = 59). The efficacy was determined by the improvement of right heart dysfunction and perfusion defect at 24 h and 14 d post UK treatment. The bleeding incidence, death rate and PE recurrence were also evaluated. RESULTS: Similarly significant improvements in right heart dysfunction and lung perfusion defects were observed in both groups. Overall bleeding incidents were low in both groups. Major bleeding directly associated with UK infusion occurred in one patient in the UK-2 h group and one in the UK-12 h group. Mortality rates were low, with one reported fatal recurrent in the UK-12 h group and none in the UK-2 h group. When the rate of bleeding, death and PE recurrence were compared separately in the hemodynamic instability and the massive anatomic obstruction subgroups, no significant difference was found. CONCLUSIONS: The UK-2 h regimen exhibits similar efficacy and safety as the UK-12 h regimen for acute PE.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2009) conducted an RCT in Acute pulmonary embolism (n=129). Urokinase vs. Urokinase bolus 4,400 U/kg followed by 2,200 U/kg·h for 12 hours was evaluated on Any improvement in pulmonary artery obstruction at 14 days (p=0.439). A 2-hour urokinase regimen exhibited similar efficacy to the standard 12-hour regimen in patients with acute pulmonary embolism, showing comparable rates of improvement in pulmonary artery obstruction at 14 days.
Synapse has enriched 10 related papers. Consider them for comparative context: